Oral acyclovir prophylaxis against herpes simplex virus in non-Hodgkin lymphoma and acute lymphoblastic leukaemia patients receiving remission induction chemotherapy. A randomised double blind, placebo controlled trial.

Forty-one patients receiving remission induction chemotherapy with vincristine, adriamycin and prednisolone (VAP) for high grade lymphoma or acute lymphoblastic leukaemia were entered into a double blind, placebo controlled trial of oral acyclovir prophylaxis against herpes simplex virus (HSV) infec...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, H., Scarffe, J. H., Sutton, R. N., Hickmott, E., Brigden, D., Burke, C.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1984
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976928/
https://www.ncbi.nlm.nih.gov/pubmed/6378236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976928/
https://www.ncbi.nlm.nih.gov/pubmed/6378236

Ejemplares similares